Product Information
LOTEMAX SM 0.38% OPHTH GEL is a brand product labeled by Bausch & Lomb Incorporated, priced at $49.4864 per GM under NDC 24208050707. Its NADAC has been published 371 times since Jul 17, 2019.
FDA first approved this application on Feb 22, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the loteprednol etabonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3.8 mg/g
Manufacturer
Bausch & Lomb IncorporatedNDC
24208050707
Classification
Brand
Dosage Form
GEL
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
LOTEPREDNOL ETABONATEApproval Type
New Drug (NDA)
FDA Application
NDA208219FDA Approved
2/22/2019
TE Code
AB
On Market Since
2/25/2019
Pharmacological Classes
Price Statistics
The NADAC for LOTEMAX SM 0.38% OPHTH GEL has been published 371 times since Jul 17, 2019, and over the history we have for it it has risen 35.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.4864 per GM |
|---|---|
| All-time high | $49.6720 (May 14, 2025) |
| All-time low | $36.5996 (Jul 17, 2019) |
| 52-week high | $49.5562 |
| 52-week low | $49.4681 |
| Median price | $46.0569 |
| Average price | $44.5613 |
| Largest weekly change | +6.0% (Jan 10, 2024) |
| Weeks tracked | 371 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the loteprednol etabonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOTEMAX SM 0.38% OPHTH GEL?
The current National Average Drug Acquisition Cost (NADAC) for LOTEMAX SM 0.38% OPHTH GEL, manufactured by Bausch & Lomb Incorporated, is $49.4864 per GM (NDC 24208050707), effective Aug 19, 2026.
How has the price of LOTEMAX SM 0.38% OPHTH GEL changed over time?
Over the history we have for it, the NADAC for LOTEMAX SM 0.38% OPHTH GEL has risen 35.2%. It has been tracked across 371 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for LOTEMAX SM 0.38% OPHTH GEL?
Since Jul 17, 2019, the NADAC for LOTEMAX SM 0.38% OPHTH GEL has ranged from a low of $36.5996 (Jul 17, 2019) to a high of $49.6720 (May 14, 2025), with a median of $46.0569 per GM.
Are there cheaper alternatives to LOTEMAX SM 0.38% OPHTH GEL?
No other NADAC-published product currently shares the active ingredient and strength of LOTEMAX SM 0.38% OPHTH GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOTEMAX SM 0.38% OPHTH GEL?
LOTEMAX SM 0.38% OPHTH GEL (NDC 24208050707) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.